Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Rotavirus Vaccines Market

ID: MRFR/HC/37310-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Rotavirus Prophylaxis Market Research Report By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines), By Administration Route (Oral, Injectable), By Age Group (Infants, Children, Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Rotavirus Prophylaxis Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 Live Attenuated Vaccines
  50.     4.1.2 Inactivated Vaccines
  51.     4.1.3 Recombinant Vaccines
  52.   4.2 Healthcare, BY Administration Route (USD Billion)
  53.     4.2.1 Oral
  54.     4.2.2 Injectable
  55.   4.3 Healthcare, BY Age Group (USD Billion)
  56.     4.3.1 Infants
  57.     4.3.2 Children
  58.     4.3.3 Adults
  59.   4.4 Healthcare, BY Distribution Channel (USD Billion)
  60.     4.4.1 Hospital Pharmacies
  61.     4.4.2 Retail Pharmacies
  62.     4.4.3 Online Pharmacies
  63.   4.5 Healthcare, BY Region (USD Billion)
  64.     4.5.1 North America
  65.       4.5.1.1 US
  66.       4.5.1.2 Canada
  67.     4.5.2 Europe
  68.       4.5.2.1 Germany
  69.       4.5.2.2 UK
  70.       4.5.2.3 France
  71.       4.5.2.4 Russia
  72.       4.5.2.5 Italy
  73.       4.5.2.6 Spain
  74.       4.5.2.7 Rest of Europe
  75.     4.5.3 APAC
  76.       4.5.3.1 China
  77.       4.5.3.2 India
  78.       4.5.3.3 Japan
  79.       4.5.3.4 South Korea
  80.       4.5.3.5 Malaysia
  81.       4.5.3.6 Thailand
  82.       4.5.3.7 Indonesia
  83.       4.5.3.8 Rest of APAC
  84.     4.5.4 South America
  85.       4.5.4.1 Brazil
  86.       4.5.4.2 Mexico
  87.       4.5.4.3 Argentina
  88.       4.5.4.4 Rest of South America
  89.     4.5.5 MEA
  90.       4.5.5.1 GCC Countries
  91.       4.5.5.2 South Africa
  92.       4.5.5.3 Rest of MEA
  93. 5 SECTION V: COMPETITIVE ANALYSIS
  94.   5.1 Competitive Landscape
  95.     5.1.1 Overview
  96.     5.1.2 Competitive Analysis
  97.     5.1.3 Market share Analysis
  98.     5.1.4 Major Growth Strategy in the Healthcare
  99.     5.1.5 Competitive Benchmarking
  100.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  101.     5.1.7 Key developments and growth strategies
  102.       5.1.7.1 New Product Launch/Service Deployment
  103.       5.1.7.2 Merger & Acquisitions
  104.       5.1.7.3 Joint Ventures
  105.     5.1.8 Major Players Financial Matrix
  106.       5.1.8.1 Sales and Operating Income
  107.       5.1.8.2 Major Players R&D Expenditure. 2023
  108.   5.2 Company Profiles
  109.     5.2.1 Merck & Co. (US)
  110.       5.2.1.1 Financial Overview
  111.       5.2.1.2 Products Offered
  112.       5.2.1.3 Key Developments
  113.       5.2.1.4 SWOT Analysis
  114.       5.2.1.5 Key Strategies
  115.     5.2.2 GlaxoSmithKline (GB)
  116.       5.2.2.1 Financial Overview
  117.       5.2.2.2 Products Offered
  118.       5.2.2.3 Key Developments
  119.       5.2.2.4 SWOT Analysis
  120.       5.2.2.5 Key Strategies
  121.     5.2.3 Sanofi (FR)
  122.       5.2.3.1 Financial Overview
  123.       5.2.3.2 Products Offered
  124.       5.2.3.3 Key Developments
  125.       5.2.3.4 SWOT Analysis
  126.       5.2.3.5 Key Strategies
  127.     5.2.4 Pfizer Inc. (US)
  128.       5.2.4.1 Financial Overview
  129.       5.2.4.2 Products Offered
  130.       5.2.4.3 Key Developments
  131.       5.2.4.4 SWOT Analysis
  132.       5.2.4.5 Key Strategies
  133.     5.2.5 Bharat Biotech (IN)
  134.       5.2.5.1 Financial Overview
  135.       5.2.5.2 Products Offered
  136.       5.2.5.3 Key Developments
  137.       5.2.5.4 SWOT Analysis
  138.       5.2.5.5 Key Strategies
  139.     5.2.6 Serum Institute of India (IN)
  140.       5.2.6.1 Financial Overview
  141.       5.2.6.2 Products Offered
  142.       5.2.6.3 Key Developments
  143.       5.2.6.4 SWOT Analysis
  144.       5.2.6.5 Key Strategies
  145.     5.2.7 Takeda Pharmaceutical Company (JP)
  146.       5.2.7.1 Financial Overview
  147.       5.2.7.2 Products Offered
  148.       5.2.7.3 Key Developments
  149.       5.2.7.4 SWOT Analysis
  150.       5.2.7.5 Key Strategies
  151.     5.2.8 Bio Farma (ID)
  152.       5.2.8.1 Financial Overview
  153.       5.2.8.2 Products Offered
  154.       5.2.8.3 Key Developments
  155.       5.2.8.4 SWOT Analysis
  156.       5.2.8.5 Key Strategies
  157.   5.3 Appendix
  158.     5.3.1 References
  159.     5.3.2 Related Reports
  160. 6 LIST OF FIGURES
  161.   6.1 MARKET SYNOPSIS
  162.   6.2 NORTH AMERICA MARKET ANALYSIS
  163.   6.3 US MARKET ANALYSIS BY TYPE
  164.   6.4 US MARKET ANALYSIS BY ADMINISTRATION ROUTE
  165.   6.5 US MARKET ANALYSIS BY AGE GROUP
  166.   6.6 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  167.   6.7 CANADA MARKET ANALYSIS BY TYPE
  168.   6.8 CANADA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  169.   6.9 CANADA MARKET ANALYSIS BY AGE GROUP
  170.   6.10 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  171.   6.11 EUROPE MARKET ANALYSIS
  172.   6.12 GERMANY MARKET ANALYSIS BY TYPE
  173.   6.13 GERMANY MARKET ANALYSIS BY ADMINISTRATION ROUTE
  174.   6.14 GERMANY MARKET ANALYSIS BY AGE GROUP
  175.   6.15 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  176.   6.16 UK MARKET ANALYSIS BY TYPE
  177.   6.17 UK MARKET ANALYSIS BY ADMINISTRATION ROUTE
  178.   6.18 UK MARKET ANALYSIS BY AGE GROUP
  179.   6.19 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  180.   6.20 FRANCE MARKET ANALYSIS BY TYPE
  181.   6.21 FRANCE MARKET ANALYSIS BY ADMINISTRATION ROUTE
  182.   6.22 FRANCE MARKET ANALYSIS BY AGE GROUP
  183.   6.23 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  184.   6.24 RUSSIA MARKET ANALYSIS BY TYPE
  185.   6.25 RUSSIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  186.   6.26 RUSSIA MARKET ANALYSIS BY AGE GROUP
  187.   6.27 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  188.   6.28 ITALY MARKET ANALYSIS BY TYPE
  189.   6.29 ITALY MARKET ANALYSIS BY ADMINISTRATION ROUTE
  190.   6.30 ITALY MARKET ANALYSIS BY AGE GROUP
  191.   6.31 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  192.   6.32 SPAIN MARKET ANALYSIS BY TYPE
  193.   6.33 SPAIN MARKET ANALYSIS BY ADMINISTRATION ROUTE
  194.   6.34 SPAIN MARKET ANALYSIS BY AGE GROUP
  195.   6.35 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  196.   6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
  197.   6.37 REST OF EUROPE MARKET ANALYSIS BY ADMINISTRATION ROUTE
  198.   6.38 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP
  199.   6.39 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  200.   6.40 APAC MARKET ANALYSIS
  201.   6.41 CHINA MARKET ANALYSIS BY TYPE
  202.   6.42 CHINA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  203.   6.43 CHINA MARKET ANALYSIS BY AGE GROUP
  204.   6.44 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  205.   6.45 INDIA MARKET ANALYSIS BY TYPE
  206.   6.46 INDIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  207.   6.47 INDIA MARKET ANALYSIS BY AGE GROUP
  208.   6.48 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  209.   6.49 JAPAN MARKET ANALYSIS BY TYPE
  210.   6.50 JAPAN MARKET ANALYSIS BY ADMINISTRATION ROUTE
  211.   6.51 JAPAN MARKET ANALYSIS BY AGE GROUP
  212.   6.52 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  213.   6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
  214.   6.54 SOUTH KOREA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  215.   6.55 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
  216.   6.56 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  217.   6.57 MALAYSIA MARKET ANALYSIS BY TYPE
  218.   6.58 MALAYSIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  219.   6.59 MALAYSIA MARKET ANALYSIS BY AGE GROUP
  220.   6.60 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  221.   6.61 THAILAND MARKET ANALYSIS BY TYPE
  222.   6.62 THAILAND MARKET ANALYSIS BY ADMINISTRATION ROUTE
  223.   6.63 THAILAND MARKET ANALYSIS BY AGE GROUP
  224.   6.64 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  225.   6.65 INDONESIA MARKET ANALYSIS BY TYPE
  226.   6.66 INDONESIA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  227.   6.67 INDONESIA MARKET ANALYSIS BY AGE GROUP
  228.   6.68 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  229.   6.69 REST OF APAC MARKET ANALYSIS BY TYPE
  230.   6.70 REST OF APAC MARKET ANALYSIS BY ADMINISTRATION ROUTE
  231.   6.71 REST OF APAC MARKET ANALYSIS BY AGE GROUP
  232.   6.72 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  233.   6.73 SOUTH AMERICA MARKET ANALYSIS
  234.   6.74 BRAZIL MARKET ANALYSIS BY TYPE
  235.   6.75 BRAZIL MARKET ANALYSIS BY ADMINISTRATION ROUTE
  236.   6.76 BRAZIL MARKET ANALYSIS BY AGE GROUP
  237.   6.77 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  238.   6.78 MEXICO MARKET ANALYSIS BY TYPE
  239.   6.79 MEXICO MARKET ANALYSIS BY ADMINISTRATION ROUTE
  240.   6.80 MEXICO MARKET ANALYSIS BY AGE GROUP
  241.   6.81 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  242.   6.82 ARGENTINA MARKET ANALYSIS BY TYPE
  243.   6.83 ARGENTINA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  244.   6.84 ARGENTINA MARKET ANALYSIS BY AGE GROUP
  245.   6.85 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  246.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  247.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  248.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP
  249.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  250.   6.90 MEA MARKET ANALYSIS
  251.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  252.   6.92 GCC COUNTRIES MARKET ANALYSIS BY ADMINISTRATION ROUTE
  253.   6.93 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP
  254.   6.94 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  255.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  256.   6.96 SOUTH AFRICA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  257.   6.97 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP
  258.   6.98 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  259.   6.99 REST OF MEA MARKET ANALYSIS BY TYPE
  260.   6.100 REST OF MEA MARKET ANALYSIS BY ADMINISTRATION ROUTE
  261.   6.101 REST OF MEA MARKET ANALYSIS BY AGE GROUP
  262.   6.102 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  263.   6.103 KEY BUYING CRITERIA OF HEALTHCARE
  264.   6.104 RESEARCH PROCESS OF MRFR
  265.   6.105 DRO ANALYSIS OF HEALTHCARE
  266.   6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  267.   6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  268.   6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
  269.   6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  270.   6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  271.   6.111 HEALTHCARE, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
  272.   6.112 HEALTHCARE, BY ADMINISTRATION ROUTE, 2024 TO 2035 (USD Billion)
  273.   6.113 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE)
  274.   6.114 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion)
  275.   6.115 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  276.   6.116 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
  277.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  278. 7 LIST OF TABLES
  279.   7.1 LIST OF ASSUMPTIONS
  280.     7.1.1
  281.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  282.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  283.     7.2.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  284.     7.2.3 BY AGE GROUP, 2025-2035 (USD Billion)
  285.     7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  286.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  287.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  288.     7.3.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  289.     7.3.3 BY AGE GROUP, 2025-2035 (USD Billion)
  290.     7.3.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  291.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  292.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  293.     7.4.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  294.     7.4.3 BY AGE GROUP, 2025-2035 (USD Billion)
  295.     7.4.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  296.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  297.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  298.     7.5.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  299.     7.5.3 BY AGE GROUP, 2025-2035 (USD Billion)
  300.     7.5.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  301.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  302.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  303.     7.6.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  304.     7.6.3 BY AGE GROUP, 2025-2035 (USD Billion)
  305.     7.6.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  306.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  307.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  308.     7.7.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  309.     7.7.3 BY AGE GROUP, 2025-2035 (USD Billion)
  310.     7.7.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  311.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  312.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  313.     7.8.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  314.     7.8.3 BY AGE GROUP, 2025-2035 (USD Billion)
  315.     7.8.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  316.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  317.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  318.     7.9.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  319.     7.9.3 BY AGE GROUP, 2025-2035 (USD Billion)
  320.     7.9.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  321.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  322.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  323.     7.10.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  324.     7.10.3 BY AGE GROUP, 2025-2035 (USD Billion)
  325.     7.10.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  326.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  327.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  328.     7.11.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  329.     7.11.3 BY AGE GROUP, 2025-2035 (USD Billion)
  330.     7.11.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  331.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  332.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  333.     7.12.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  334.     7.12.3 BY AGE GROUP, 2025-2035 (USD Billion)
  335.     7.12.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  336.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  337.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  338.     7.13.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  339.     7.13.3 BY AGE GROUP, 2025-2035 (USD Billion)
  340.     7.13.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  341.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  342.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  343.     7.14.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  344.     7.14.3 BY AGE GROUP, 2025-2035 (USD Billion)
  345.     7.14.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  346.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  347.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  348.     7.15.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  349.     7.15.3 BY AGE GROUP, 2025-2035 (USD Billion)
  350.     7.15.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  351.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  352.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  353.     7.16.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  354.     7.16.3 BY AGE GROUP, 2025-2035 (USD Billion)
  355.     7.16.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  356.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  357.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  358.     7.17.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  359.     7.17.3 BY AGE GROUP, 2025-2035 (USD Billion)
  360.     7.17.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  361.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  362.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  363.     7.18.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  364.     7.18.3 BY AGE GROUP, 2025-2035 (USD Billion)
  365.     7.18.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  366.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  367.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  368.     7.19.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  369.     7.19.3 BY AGE GROUP, 2025-2035 (USD Billion)
  370.     7.19.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  371.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  372.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  373.     7.20.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  374.     7.20.3 BY AGE GROUP, 2025-2035 (USD Billion)
  375.     7.20.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  376.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  377.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  378.     7.21.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  379.     7.21.3 BY AGE GROUP, 2025-2035 (USD Billion)
  380.     7.21.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  381.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  382.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  383.     7.22.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  384.     7.22.3 BY AGE GROUP, 2025-2035 (USD Billion)
  385.     7.22.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  386.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  387.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  388.     7.23.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  389.     7.23.3 BY AGE GROUP, 2025-2035 (USD Billion)
  390.     7.23.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  391.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  392.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  393.     7.24.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  394.     7.24.3 BY AGE GROUP, 2025-2035 (USD Billion)
  395.     7.24.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  396.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  397.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  398.     7.25.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  399.     7.25.3 BY AGE GROUP, 2025-2035 (USD Billion)
  400.     7.25.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  401.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  402.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  403.     7.26.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  404.     7.26.3 BY AGE GROUP, 2025-2035 (USD Billion)
  405.     7.26.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  406.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  407.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  408.     7.27.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  409.     7.27.3 BY AGE GROUP, 2025-2035 (USD Billion)
  410.     7.27.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  411.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  412.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  413.     7.28.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  414.     7.28.3 BY AGE GROUP, 2025-2035 (USD Billion)
  415.     7.28.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  416.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  417.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  418.     7.29.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  419.     7.29.3 BY AGE GROUP, 2025-2035 (USD Billion)
  420.     7.29.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  421.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  422.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  423.     7.30.2 BY ADMINISTRATION ROUTE, 2025-2035 (USD Billion)
  424.     7.30.3 BY AGE GROUP, 2025-2035 (USD Billion)
  425.     7.30.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  426.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  427.     7.31.1
  428.   7.32 ACQUISITION/PARTNERSHIP
  429.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines

Healthcare By Administration Route (USD Billion, 2025-2035)

  • Oral
  • Injectable

Healthcare By Age Group (USD Billion, 2025-2035)

  • Infants
  • Children
  • Adults

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions